DI-076 Clinical experience with darunavir plus cobicistat combination in human immunodeficiency virus treatment

BackgroundDarunavir/cobicistat (DRV/COBI) is an antiviral medicine recently approved in our hospital for simplifying the posology of patients previously treated with darunavir 800 mg and ritonavir 100 mg, in combination with other medicines.PurposeTo evaluate the short term efficacy and safety of DR...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A147-A147
Hauptverfasser:	Luiz, A Tomás, Naranjo, L Menéndez, Rivadeneyra, M Almanchel, González, A Mancebo, Ávila, JJ Fernández
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral drugs Computerized physician order entry Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!